Integration of Molecular Information in Risk Assessment of Patients with Myeloproliferative Neoplasms.

Abstract excerpt

Philadelphia chromosome-negative myeloproliferative neoplasms (MPN) are clonal disorders of a hematopoietic stem cell, characterized by an abnormal proliferation of largely mature cells driven by mutations in JAK2, CALR, and MPL. All these mutations lead to a constitutive activation of the JAK-STAT signaling, which represents a target for therapy. Beyond driver ones, most patients, especially with myelofibrosis,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Calreticulin
• Share to Dioxygenases
• Share to DNA-Binding Proteins